524
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Evaluation

Linagliptin for the treatment of type 2 diabetes

Evaluation of Del Prato S, Barnett AH, Huisman H, et al. Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 2011;13:258-67

Pages 2759-2762 | Published online: 02 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

John Doupis. (2014) Linagliptin: from bench to bedside. Drug Design, Development and Therapy 8, pages 431-446.
Read now
Lene Hoimark, Torben Laursen & Jørgen Rungby. (2012) Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 5, pages 295-302.
Read now

Articles from other publishers (2)

Je-Yon Kim, Seungwon Yang, Jangik I. Lee & Min Jung Chang. (2016) Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis. PLOS ONE 11:4, pages e0153502.
Crossref
Alexandre Hohl. (2014) Linagliptin: DPP-4 Inhibition in the Treatment of Type 2 Diabetes Mellitus. Journal of Diabetes, Metabolic Disorders & Control 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.